Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study
Effect of Astragalus membranaceus on primary outcome measures in acute hemorrhagic stroke patients. The increase of FIM scale scores in the group A was greater than in the group B in week 4 and in week 12 in acute hemorrhagic stroke patients. Group A: complementary therapy with Astragalus membranaceus; Group B: complementary therapy with placebo; FIM: functional independence measure; BI: Barthel index; GOS: Glasgow outcome scale; MRS: Modified Rankin scale; B: baseline (week 1); W4: week 4; W12: week 12; (a) ; (b) ; (c) compared to the increase of Group B.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.